文献速递生殖医学妇科

卵巢子宫内膜异位症女性的生育力保存:一项回顾性队列研究结果

Fertility preservation for women with ovarian endometriosis: results from a retrospective cohort study.
PubMed 文献 · Reprod Biomed Online · 2022-12-02

该回顾性队列纳入2016年至2021年在两家体外受精中心接受生育力保存治疗的71名卵巢子宫内膜异位症女性,共138个周期,中位年龄31岁。主要结局为获卵的减数第二次分裂中期(MII)卵母细胞数。生育力保存前接受过卵巢子宫内膜异位症手术者MII卵母细胞数减少51.7%(95%CI 26.1至68.5,P=0.001)。结论推荐与患者讨论生育力保存方案,尤其计划手术时。

要点

  • 生育力保存前接受卵巢子宫内膜异位症手术者MII卵母细胞数减少51.7%(95%CI 26.1至68.5,P=0.001)。
  • 未手术亚组中,子宫内膜异位囊肿大于4 cm者与4 cm及以下者抗苗勒管激素、获卵数及MII卵母细胞数相似。
  • 作者推荐与卵巢子宫内膜异位症患者讨论生育力保存方案,尤其计划手术时。

核心结论

  • 作者推荐与卵巢子宫内膜异位症患者讨论生育力保存治疗方案,尤其当计划手术时。

研究设计与样本

  • 回顾性队列研究,纳入2016年至2021年在两家体外受精中心接受生育力保存治疗、经组织学或超声确诊卵巢子宫内膜异位症的71名女性,共138个生育力保存周期,中位年龄31岁。

主要发现

  • 71名女性中40名(56%)在生育力保存治疗前至少接受过一次卵巢子宫内膜异位症手术。
  • 采用每位患者第一个周期的多因素分析显示,生育力保存前接受卵巢子宫内膜异位症手术者MII卵母细胞数较未手术者减少51.7%(95%CI 26.1至68.5,P=0.001)。
  • 未手术亚组中,子宫内膜异位囊肿大于4 cm者与4 cm及以下者相比,抗苗勒管激素浓度为2.6 ng/ml vs 2.1 ng/ml,获卵数为9 vs 9,MII卵母细胞数为7.6 vs 7,均相似。

临床怎么用

  • 作者推荐与卵巢子宫内膜异位症患者讨论生育力保存治疗方案,尤其当计划手术时。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: What is the outcome of fertility-preservation treatments in women with endometrioma, especially those with endometrioma larger than 4 cm? DESIGN: Retrospective cohort study. Women with definitive diagnosis of ovarian endometriosis (by histology or ultrasound), who underwent fertility-preservation treatment in two IVF units between 2016 and 2021, were included. As some women cryopreserved oocytes and other embryos, the primary outcome was the number of metaphase II (MII) oocytes retrieved. RESULTS: Seventy-one women with ovarian endometriosis (OMA) underwent 138 fertility-preservation cycles. The median age of patients was 31 years. Forty out of 71 (56%) women underwent at least one surgery for OMA before fertility-preservation treatment. Multivariate analysis of each patient's first cycle was used. Women who underwent OMA surgery before fertility-preservation treatment had a 51.7% reduction (95% CI 26.1 to 68.5, P = 0.001) in the number of MII oocytes compared with women with OMA who did not undergo surgery. Among a subgroup who did not undergo surgery, those with an endometrioma larger than 4 cm had similar anti-Müllerian hormone concentration (2.6 ng/ml versus 2.1 ng/ml), number of oocytes retrieved (9 versus 9) and number of MII oocytes (7.6 versus seven 7) compared with women with an endometrioma of 4 cm or less. CONCLUSIONS: Discussing fertility-preservation treatment options with patients with OMA is recommended, especially if surgery is planned.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Elizur SE, Aizer A, Yonish M, et al. Fertility preservation for women with ovarian endometriosis: results from a retrospective cohort study. Reprod Biomed Online. 2022. PMID: 36564221. doi:10.1016/j.rbmo.2022.11.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。